Erratum: Corrections to discovery of (Z)-5-(4-Methoxybenzylidene) thiazolidine-2,4-dione, a readily available and orally active glitazone for the treatment of concanavalin a-induced acute liver injury of BALB/c mice (Journal of Medicinal Chemistry (2010) 53 (273) DOI: 10.1021/jm901183d);Discovery of (Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione, a readily available and orally active glitazone for the treatment of concanavalin A-induced acute liver injury of BALB/c mice

Journal of Medicinal Chemistry

Volumn 53, Issue 1, 2010, Pages 273-281

  Luo, Youfu ^a   Ma, Liang ^a   Zheng, Hao ^a   Chen, Lijuan ^a   Li, Rui ^a   He, Chunmei ^a   Yang, Shengyong ^a   Ye, Xia ^a   Chen, Zhizhi ^a   Li, Zicheng ^b   Gao, Yan ^b   Han, Jing ^a   He, Gu ^a   Yang, Li ^a   Wei, Yuquan ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 3 (4 HYDROXY 3 METHOXYBENZYLIDENE)PYRROLIDINE 2,5 DIONE; 5 (4 METHOXYBENZYLIDENE) 2 THIOXODIHYDROPYRIMIDINE 4,6(1H,5H) DIONE; 5 (4 METHOXYBENZYLIDENE)THIAZOLIDINE 2,4 DIONE; 5 [4 (DIMETHYLAMINO)BENZYLIDENE] 2 THIOXODIHYDROPYRIMIDINE 4,6(1H,5H) DIONE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CONCANAVALIN A; GLITAZONE DERIVATIVE; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BAGG ALBINO MOUSE; CHEMOTAXIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SYNTHESIS; FEMALE; HISTOPATHOLOGY; LIVER INJURY; LIVER PROTECTION; MOUSE; NONHUMAN;

EID: 74849086887     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm100431z     Document Type: Erratum

References (19)

1. Holt,M. P.; Cheng, L.; Ju, C. Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J. Leukocyte Biol. 2008, 84, 1410-1421.
2. Duffield, J. S.; Forbes, S. J.; Constandinou, C. M.; Clay, S.; Partolina, M.; Vuthoori, S.; Wu, S.; Lang, R.; Iredale, J. P. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 2005, 115, 56-65.
3. Czaja, M. J.; Geerts, A.; Xu, J.; Schmiedeberg, P.; Ju, Y. Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J. Leukocte Biol. 1994, 55, 120-126.
4. Marra, F.; Romanelli, R. G.; Giannini, C.; Failli, P.; Pastacaldi, S.; Arrighi, M. C.; Pinzani, M.; Laffi, G.; Montalto, P.; Gentilini, P. Monocyte Chemotactic Protein-1 as a Chemoattractant for Human Hepatic Stellate Cells. Hepatology 1999, 29, 140-148.
5. Melgarejo, E.; Medina, M. A.; Sánchez-Jiménez, F.; Urdiales, J. L. Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int. J. Biochem. Cell Biol. 2009, 41, 998-1001.
6. Shin, W. S.; Szuba, A.; Rockson, S. G. The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis 2002, 160, 91-102.
7. Grandaliano, G.;Gesualdo, L.; Ranieri, E.; Monno, R.;Montinaro, V.; Marra, F.; Schena, F. P. Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. J. Am. Soc. Nephrol. 1996, 7, 906-913.
8. Zhang, K.; Phan, S. H. Cytokines and pulmonary fibrosis. Biol. Signals 1996, 5, 232-239.
9. Usui, M.; Egashira, K.; Ohtani, K.; Kataoka, C.; Ishibashi, M.; Hiasa, K.-I.; Katoh, M.; Kitamoto, S.; Takeshita, A. Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys. FASEB J. 2002, 16, 1838-1840.
10. Taylor, P. C.; Peters, A. M.; Paleolog, E.; Chapman, P. T.; Elliott, M. J.; McCloskey, R.; et al. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthrit. Rheum. 2000, 43, 38-47.
11. O'Hayre, M.; Salanga, C. L.; Handel, T. M.; Allen, S. J. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem. J. 2008, 409, 635-49.
12. Van Coillie, E.; Van Damme, J.; Opdenakker, G. The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev. 1999, 10, 61-86.
13. Yatrik, M.; Shah, K. M.; Frank, J. G. Expression of peroxisome proliferator-activated receptor-γ in macrophage suppresses experimentally induced colitis. Am. J. Physiol., Gastrointest. Liver Physiol. 2007, 292, G657-G666.
14. 2 reduces the liver injury in endotoxic shock. Eur. J. Pharmacol. 2003, 29, 257-258.
15. Ohata, M.; Suzuki, H.; Sakamoto, K; Hashimoto, K; Nakajima, H; Yamauchi, M; Hokkyo, K; Yamada, H; Toda, G. Pioglitazone Prevents Acute Liver Injury Induced by Ethanol and Lipo-polysaccharide Through the Suppression of Tumor Necrosis Factor-(alpha). Alcohol: Clin. Exp. Res. 2004, 28, 139S-144S.
16. Yki-Jarvinen, H. Drug Therapy - Thiazolidinediones. N. Engl. J. Med. 2004, 351, 1106-1118.
17. Xu, Z.; Knaak, C.; Ma, J.; Beharry, Z. M.; McInnes, C.; Wang, W.; Kraft, A. S.; Smith, C. D. Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases. J. Med. Chem. 2009, 52, 74-86.
18. Camps, M.; Ruckle, T.; Ji, H.; Ardissone, V.; Rintelen, F.; Shaw, J.; Ferrandi, C.; Chabert, C.; Gillieron, C.; Francon, B.; Martin, T.; Gretener, D.; Perrin, D.; Leroy, D.; Vitte, P.-A.; Hirsch, E.; Wymann,M.P.; Cirillo, R.; Schwarz,M.K.; Rommel, C. Blockade of PI3kg suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nature Med. 2005, 11, 936-941.
19. Wang, Z.; Wu, X.; Song, L.; Wang, Y.; Hu, X.; Luo, Y.; Chen, Z.; Ke, J.; Peng, X.; He, C.; Zhang, W.; Chen, L.; Wei, Y. Phosphoinositide 3-kinase γ inhibitor ameliorates concanavalin A-induced hepatic injury in mice. Biochem. Biophys. Res. Commun. 2009, 386, 569-574.